Skip to main content

Table 4 Ejection fraction % in both groups

From: Myocardial protection with histidine-tryptophan-ketoglutarate solution in comparison with hypothermic hyperkalemic blood solution in the correction of acyanotic congenital heart diseases

 

Group

P*

HTK

HHB

Mean

±SD

Median

IQR

Mean

±SD

Median

IQR

Preoperative EF%

60.50

3.95

60.00

58.00

62.00

61.17

7.10

60.00

56.00

64.00

0.655

Postoperative EF% (post CPB) at 0 h

60.90

4.26

62.00

58.00

63.00

61.83

10.41

62.00

58.00

66.00

0.652

Postoperative EF% at 24 h

58.67

3.30

59.00

57.00

62.00

59.13

7.47

59.00

55.00

63.00

0.756

Postoperative EF% at 48 h

59.73

3.62

61.00

57.00

63.00

59.80

6.36

61.50

56.00

63.00

0.960

  1. EF ejection fraction, CPB cardiopulmonary bypass, HTK histidine-tryptophan-ketoglutarate, HHB hypothermic hyperkalemic blood, SD standard deviation, IQR interquartile range; *Student’s t test
  2. P value < 0.05 was considered significant